How Brazil is becoming a more favourable jurisdiction for life sciences patentees

How Brazil is becoming a more favourable jurisdiction for life sciences patentees

Contrary to appearances, Latin America’s largest economy is developing a more favourable environment for pharma and biotech innovators.

Unlock unlimited access to all IAM content